Bank Julius Baer & Co. Ltd Zurich Has $58,000 Position in Colgate-Palmolive Company $CL

Bank Julius Baer & Co. Ltd Zurich lowered its stake in Colgate-Palmolive Company (NYSE:CL) by 91.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 732 shares of the company’s stock after selling 8,093 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in Colgate-Palmolive were worth $58,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. HighPoint Advisor Group LLC grew its holdings in Colgate-Palmolive by 0.7% during the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after acquiring an additional 109 shares during the period. Sunpointe LLC grew its holdings in Colgate-Palmolive by 4.0% during the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after acquiring an additional 117 shares during the period. Capital Advisors Inc. OK grew its holdings in Colgate-Palmolive by 1.4% during the 4th quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock worth $758,000 after acquiring an additional 129 shares during the period. Stratos Wealth Advisors LLC grew its holdings in Colgate-Palmolive by 4.5% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after acquiring an additional 130 shares during the period. Finally, Eads & Heald Wealth Management grew its holdings in Colgate-Palmolive by 0.6% during the 4th quarter. Eads & Heald Wealth Management now owns 20,744 shares of the company’s stock worth $1,639,000 after acquiring an additional 132 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

CL has been the subject of a number of analyst reports. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $102.00 target price on shares of Colgate-Palmolive in a report on Monday, May 4th. Barclays lifted their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 5th. Jefferies Financial Group lifted their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Bank of America lowered their target price on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a report on Friday, April 10th. Finally, Rothschild & Co Redburn set a $100.00 target price on shares of Colgate-Palmolive and gave the stock a “buy” rating in a report on Tuesday, April 21st. Twelve analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $95.88.

Key Stories Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Shareholders backed the company’s board, executive pay practices, and auditor, signaling continued investor support for management and governance. Article Title
• Neutral Sentiment: Zacks Research slightly lowered its longer-term earnings outlook for Colgate-Palmolive, including FY2027 to $4.01 from $4.15 and FY2028 to $4.39 from $4.44, while keeping estimates near the broader consensus.
• Negative Sentiment: The firm also cut near-term estimates, including FY2026 to $3.80 from $3.89, Q2 2026 to $0.95 from $0.97, Q3 2026 to $0.91 from $0.96, and Q4 2026 to $0.96 from $1.00, raising concern about modest earnings headwinds.
• Negative Sentiment: Additional trims to 2027 and 2028 quarterly forecasts point to a softer earnings trajectory, which can weigh on sentiment for a stable consumer staples stock like Colgate-Palmolive.

Colgate-Palmolive Price Performance

NYSE CL opened at $88.20 on Monday. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. The stock has a market cap of $70.76 billion, a price-to-earnings ratio of 34.32, a PEG ratio of 4.58 and a beta of 0.31. The business has a 50 day simple moving average of $86.30 and a 200 day simple moving average of $84.73. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same quarter in the prior year, the company earned $0.91 earnings per share. The business’s quarterly revenue was up 8.4% compared to the same quarter last year. Analysts anticipate that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were given a $0.53 dividend. The ex-dividend date of this dividend was Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s payout ratio is presently 82.49%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.